MSH2 p.Pro622Arg
Variant summary
The NM_000251.3(MSH2):c.1865C>G (p.Pro622Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. The affected nucleotide is highly conserved across species (PhyloP 100-way vertebrate score: 7.20). Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000322563: Published functional studies suggest a damaging effect: resistance to 6-TG similar to known pathogenic variants (PMID:33357406)" and additional evidence is available in ClinVar. A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.P622T: Pathogenic/Likely_pathogenic (ClinVar VariationId 90805, 2 stars) Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.P622A: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 186899); p.P622= (synonymous): Benign/Likely_benign (ClinVar VariationId 232372, 2 stars); p.P622= (synonymous): Likely_benign (ClinVar VariationId 1078844, 1 star)
Frequency
Consequence
NM_000251.3 missense
Scores
Clinical Significance
Conservation
Publications
- Lynch syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, G2P, Orphanet
- Lynch syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
- mismatch repair cancer syndrome 1Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- mismatch repair cancer syndrome 2Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- Muir-Torre syndromeInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- ovarian cancerInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- malignant pancreatic neoplasmInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- prostate cancerInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- rhabdomyosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- breast cancerInheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
Classification according to ACMG Germline Pathogenicity v2019
Our verdict: Pathogenic. The variant received 16 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| PS3Functional studies show damaging effect | Well-established functional study supports damaging effect (PS3); SCV000322563: Published functional studies suggest a damaging effect: resistance to 6-TG similar to known pathogenic variants (PMID: 33357406); SCV000601444: Assessment of experimental evidence suggests this variant results in abnormal protein function (PMID: 33357406 (2021)).; SCV000580538: "In a massively parallel cell-based functional assay testing susceptibility to a DNA damaging agent, 6-thioguanine (6-TG), this variant was determined to be functionally deleterious (Jia X et al. Am J Hum Genet, 2021 Jan;108:163-175)."; SCV000750648: Experimental studies have shown that this missense change affects MSH2 function (PMID: 33357406).; SCV004186682: Functional studies indicate this variant impacts protein function [PMID: 33357406]. | ||
| PM2Absent/extremely low in population databases | Absent from gnomAD (AD/XL gene) — PM2; Absent from gnomAD at well-covered site (MOI: AD+AR) (base 0.0001, raised to 0.0005 by highest known P/LP ClinVar AF 0.00268) — PM2 moderate. | ||
| PM5Novel missense at known pathogenic residue | Different pathogenic missense at same AA residue in ClinVar (PM5); ClinVar contains a germline Pathogenic/Likely Pathogenic entry at the same amino acid position with a different amino acid change: p.P622T: Pathogenic/Likely_pathogenic (ClinVar VariationId 90805, 2 stars); Other variants at the same amino acid residue (not pathogenic): p.P622A: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 186899); p.P622= (synonymous): Benign/Likely_benign (ClinVar VariationId 232372, 2 stars); p.P622= (synonymous): Likely_benign (ClinVar VariationId 1078844, 1 star) | ||
| PP3Computational evidence supports damaging effect | Germline meta computational scorer (REVEL/MetaRNN/BayesDel) predicts damaging effect — strong evidence (PP3); Splicing verdict: not pathogenic.; Germline computational verdict: pathogenic (Strong). | ||
| PP5Reputable source reports pathogenic | ClinVar 2-star pathogenic — strong (PP5); ClinVar germline classification: Pathogenic/Likely Pathogenic, 2 star(s). |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_000251.3. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
MSH2 | MANE Select | c.1865C>G p.Pro622Arg | missense | Exon 12 of 16 | Prot: NP_000242.1 UniProt: | |
MSH2 | c.1865C>G p.Pro622Arg | missense | Exon 12 of 18 | Prot: NP_001393603.1 | ||
MSH2 | c.1865C>G p.Pro622Arg | missense | Exon 12 of 18 | Prot: NP_001393560.1 |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
MSH2 | TSL:1MANE Select | c.1865C>G p.Pro622Arg | missense | Exon 12 of 16 | Prot: ENSP00000233146.2 UniProt: | |
MSH2 | TSL:1 | c.1865C>G p.Pro622Arg | missense | Exon 12 of 16 | Prot: ENSP00000384199.1 UniProt: | |
MSH2 | c.1916C>G p.Pro639Arg | missense | Exon 13 of 17 | Prot: ENSP00000588166.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 3 sources | |||||
GnomAD3 genomes | Cov:32 | ||||
GnomAD4 exome | Cov:33 | ||||
GnomAD4 genome | Cov:32 | ||||
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 30 | |
AlphaMissense | Pathogenic | 0.99 | |
BayesDel_addAF | Pathogenic | 0.58 | D |
BayesDel_noAF | Pathogenic | 0.59 | |
CADD | Pathogenic | 28 | |
DANN | Uncertain | 1.0 | |
DEOGEN2 | Pathogenic | 0.94 | D |
Eigen | Pathogenic | 1.1 | |
Eigen_PC | Pathogenic | 1.0 | |
FATHMM_MKL | Pathogenic | 0.99 | D |
FuncVEP CTI | Pathogenic | 0.97 | |
GPN-Star LLR | N/A | -7.4 | |
GPN-Star score | N/A | 7.4 | |
LIST_S2 | Uncertain | 0.97 | D |
M_CAP | Pathogenic | 0.37 | D |
MetaRNN | Pathogenic | 0.99 | D |
MetaSVM | Pathogenic | 1.0 | D |
Mutation Taster | N/A | 3/97 | disease causing (ClinVar) |
MutationAssessor | Pathogenic | 4.6 | H |
PhyloP100 | Uncertain | 7.2 | |
popEVE | Benign | -4.0 | |
PrimateAI | Uncertain | 0.65 | T |
PROVEAN | Pathogenic | -8.8 | D |
REVEL | Pathogenic | 0.96 | |
Sift | Pathogenic | 0.0 | D |
Sift4G | Pathogenic | 0.0 | D |
Varity_R | N/A | 0.94 | |
VESM-3B | Benign | -15 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.0 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.
MaveDB functional evidence
- Gene
- MSH2
- Assay type
- Cell fitness
- Mechanism
- DNA and Mismatch repair
- Model system
- Immortalized human cells (Homo sapiens)
- Score
- 1.88 · p.Pro622Arg (assay numbering)